Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Tony Mok Michael J. Boyer |
| Publication date | February 7, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |